688029 Micro-Tech
- 60.09
- -0.82-1.35%
Micro-Tech News
Despite Delivering Investors Losses of 57% Over the Past 3 Years, Micro-Tech (Nanjing)Ltd (SHSE:688029) Has Been Growing Its Earnings
Micro-tech (688029.SH): has repurchased 0.1% of shares.
On September 3, Gelonhui reported that as of August 31, 2024, Micro-tech (688029.SH) has repurchased a total of 187,338 shares, accounting for 0.10% of the total share capital. The highest purchase price was 62.74 yuan/per share, and the lowest price was 55.85 yuan/per share. The total amount paid was 11,086,557.13 yuan (excluding stamp duty, trading commissions, and other transaction fees).
Will Weakness in Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Stock Prove Temporary Given Strong Fundamentals?
Summary of the 2024 semi-annual report of Micro-Tech Medical Technology Co., Ltd.
Micro-tech Medical Technology Co., Ltd. 2024 Semi-Annual Report
Shareholder Huakang of Micro-Tech (688029.SH) has completed the shareholding reduction period and has collectively reduced 3.7151 million shares.
Micro-tech (688029.SH) announced that its shareholder, Huakang Limited (referred to as...)...
Micro-tech (688029.SH): Shareholder Huakang reduced its shareholding percentage to 5%.
Micro-tech (688029.SH) announced that from July 25, 2024 to August 6, 2024, the company...
Micro-tech (688029.SH): Has repurchased 0.04% of its shares.
On August 1st, Gelunhui announced that as of July 31, 2024, the company has cumulatively repurchased 82,890 shares, accounting for 0.04% of the total share capital of the company. The highest purchase price was 62.74 yuan/share, the lowest was 58.30 yuan/share, and the total amount paid was 5,111,787.00 yuan (excluding stamp duty, transaction commission and other transaction costs).
Micro-tech (688029.SH): There is no production capacity in the USA, and there are no plans to produce in the USA at present.
Micro-Tech (688029.SH) stated on the interactive platform on July 31 that the company has no production capacity in the USA and has no plans to produce in the USA.
Micro-tech (688029.SH)'s subsidiary Kangyou Medical plans to increase capital and expand by implementing stock-based incentives for employees.
Micro-tech (688029.SH) announced that its subsidiary, Nanjing Kangyou Medical Technology Co., Ltd. (referred to as "..."
Micro-tech (688029.SH): first buyback of 0.03% shares involving 3.8878 million yuan.
On July 17th, Gelonhui reported that Micro-tech (688029.SH) bought back 62,090 shares of its own stock through the Shanghai Stock Exchange trading system using centralized bidding trading for the first time, accounting for 0.03% of the company's total share capital of 187,847,422 shares. The highest buyback price was 62.74 yuan/share, the lowest was 62.47 yuan/share, and the total amount paid was RMB 3,887,822.86 (excluding stamp duty, transaction commission and other trading fees). This share buyback complies with relevant laws and regulations.
Retail Investors Are Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥947m Last Week
Micro-Tech (688029.SH): Chairman Long Xiaohui proposes to repurchase shares for 20-40 million yuan.
On July 8th, Gelunhui reported that Micro-Tech (688029.SH) proposed to repurchase some social public shares of the company through centralized bidding trading, based on the company's operation and financial condition and other factors, and in accordance with relevant laws and regulations, initiated by Chairman Long Xiaohui. The total amount of repurchase funds in this transaction is no less than RMB 20 million (inclusive) and no more than RMB 40 million (inclusive).
Here's What's Concerning About Micro-Tech (Nanjing)Ltd's (SHSE:688029) Returns On Capital
Micro-tech (688029.SH) will distribute RMB 10 yuan for every 10 shares in 2023, with the share registration day on June 21.
Nanwei Medical (688029.SH) announced that it will distribute an annual equity dividend in 2023, with a cash dividend of 10 yuan (including tax) for every 10 shares. The record date for shareholders is June 21.
Is Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nanwei Medical (688029.SH): Appoints Li Changqing as the company's executive president
Gelonghui, May 20 | Nanwei Medical (688029.SH) announced that the board of directors agreed to appoint Mr. CHANGQING LI (Li Changqing) as the company's executive president. His role is to assist the president to preside over the overall production and operation management of the company in accordance with the president's authorization. The term of office starts from the date of review and approval by the board of directors and ends on the date the term of the third board of directors expires.
Huakang Limited, the major shareholder of Nanwei Medical (688029.SH), reduced its holdings by 1.04%
Southern Weimedicine (688029.SH) Notice, May 15, 2024 to May 17, 2024, Public...
Nanwei Medical (688029.SH) released 2023 annual results, with net profit of 486 million yuan, an increase of 46.99% over the previous year
Nanwei Medical (688029.SH) released its 2023 annual report. The company achieved operating income of 24 during the reporting period...
Nanwei Medical (688029.SH): Shareholder Huakang Limited plans to reduce its total holdings by no more than 1.99%
On April 18, Ge Longhui Medical (688029.SH) announced that due to its own capital requirements, Huakang Limited plans to reduce the total holdings of the company's shares by no more than 3,738,163 shares through centralized bidding and bulk transactions through the Shanghai Stock Exchange trading system. Of these, those planning to reduce their holdings through centralized bidding transactions on the stock exchange will reduce their holdings by no more than 1,878,474 shares within 90 days (May 15 to August 12, 2024) after the disclosure of the shareholding reduction plan announcement. and any 90 consecutive times
Analysis
Price Target
No Data
No Data